Therapeutic Design And Approaches
Explore how we are enabling therapeutic development of our own and for the entire cell and gene therapy industry.
Accelerating Cell and Gene Therapy Development
ElevateBio® is enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging in-house capabilities and expertise to design and develop an array of modalities. Alongside advancing our own pipeline of therapeutics, we are powering our partners to develop and advance cell and gene therapies for a range of devastating cancers and genetic diseases through our technology platforms and end-to-end capabilities.
Driving a Diverse Array of Modalities
We have expansive expertise to design, develop and manufacture ex vivo and in vivo cell and gene therapies across a range of therapeutic designs.
- Ex Vivo Cell & Gene Therapies - We design, develop and manufacture ex vivo cell and gene therapies, including autologous and allogeneic cell therapies, iPSC-derived regenerative medicines, and proprietary lentiviral vectors. Click here to learn more.
- In Vivo Gene Therapies - Our platform technologies are powering therapeutic programs with curative potential for the most challenging genetic disorders. We have the capabilities and expertise to lead the next generation of gene-edited and RNA-derived therapies. Click here to learn more.
Partner with ElevateBio®
Wherever you are in your cell and gene therapy product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.